设计一种含有富罗斯米德纳米颗粒的口服药片,其生物可用性提高
Noriaki Nagai1, Fumihiko Ogata1, Reita Kadowaki1
1Faculty of Pharmacy, Kindai University.
Journal of oleo science
|March 31, 2024
概括
口服分解片含富胺 (FUR) 纳米颗粒显著提高口服生物可用性. 这种新型配方增强FUR吸收,并可能改善其他生物制药分类系统IV类药物.
科学领域:
- 制药科学 制药科学
- 药物输送系统 药物输送系统
背景情况:
- 生物制药分类系统 (BCS) 第四类药物具有较差的溶解性和透性,限制了口服生物利用性.
- 罗塞米德 (FUR) 是BCS第四类药物,需要采取策略来增强其口服吸收.
研究的目的:
- 设计和开发口服分解药片 (ODT),其中包含化 (FUR) 纳米颗粒.
- 评估FUR装载ODT提高口服生物利用性的潜力.
主要方法:
- 使用甲基纤维素和2-基-β-环氧素进行珠子研磨,制备了FUR纳米颗粒.
- 使用D-曼尼托,聚烯和牙膏阿拉伯语,用FUR纳米颗粒制成ODT,然后冷干燥.
- 评估了小鼠的药片分解,纳米粒子释放和体内吸收.
主要成果:
- 珠子研磨产生了FUR纳米粒子,平均尺寸为188纳米.
- 开发的FUR-NP片在5秒内分解,释放出纳米尺寸的FUR颗粒.
- 与传统的FUR微粒颗粒片相比,FUR-NP片在老鼠口服时显著改善了吸收.
结论:
- 含有FUR纳米颗粒的口服分解片有效地提高了furosemide的口服生物可用性.
- 这种配方方法有望改善其他具有挑战性的BCS IV类药物的输送.
相关概念视频
Factors Affecting Dissolution: Particle Size and Effective Surface Area
828
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
828
Factors Influencing Drug Absorption: Pharmaceutical Parameters
133
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
133
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
206
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
206
Factors Influencing Drug Absorption: Presystemic Elimination
215
The pharmacokinetic journey of oral drugs begins with a crucial first pass through the hepatic portal system, called the first-pass effect. This first pass significantly impacts bioavailability — the proportion of a drug that enters systemic circulation and is available for therapeutic action. The primary route sees the drug absorbed by intestinal membranes and then shunted to the liver via the hepatic portal vein. Here, pre-systemic elimination occurs as drugs face metabolism or biliary...
215
Factors Influencing Drug Absorption: Physicochemical Parameters
274
The physicochemical characteristics of drugs play a crucial role in formulating stable and bioavailable drug products. The solubility of a drug, governed by the varying pH along the GI tract and its dissociation constant (pKa), is pivotal in determining its ionization state and absorption rate. Notably, weak acids and bases remain unionized and are absorbed more rapidly.
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
274
Factors Influencing Bioavailability: First-Pass Elimination
6.3K
When a drug is taken orally, it undergoes a journey starting from the gastrointestinal (GI) tract, passing through the portal vein, reaching the liver, and finally entering the systemic circulation. This process involves the absorption of the drug across the GI tract. The liver is the primary site for metabolizing the drug, with some metabolism also occurring in the gut wall. This journey significantly reduces the quantity of the drug that reaches the systemic circulation, a phenomenon known as...
6.3K


